HLA-G and Alzheimer disease: Urinary β2-microglobulin levels were significantly increased in the AD group compared to the control group, and a substantial reduction was observed in the dapagliflozin, NEPROBIN 200 mg, and NEPROBIN 400 mg treatment groups, showing a reduction of 44%, 24.9%, and 25.2%, respectively (Figure 4F).